Posted in | News | Nanobusiness

Nanotechnology Corporation Capital AG Registration Process Completed

RUSNANO announces the completion of its incorporation and registration procedure for the investment management company RUSNANO Capital AG. RUSNANO Capital AG will be involved in attracting global investors for financing promising Russian innovative projects as well as investing in existing Western innovative technologies with the aim of implementing them in Russia.

RUSNANO Capital AG is registered in Switzerland and will monitor and maintain control over the establishment and activities of funds invested in specialized in innovative technologies. Andreas Kazutt, a partner in the law firm “Niederer Kraft & Frey”, has been appointed as the Local Director of RUSNANO Capital AG in Zurich.

RUSNANO is the exclusive shareholder of RUSNANO Capital AG and for the purpose of conducting consulting activities in Russia a subsidiary company called RUSNANO Capital LLC has been incorporated. RUSNANO Capital LLC is headed by Irina Rapoport.

RUSNANO Capital AG Board Members are:
Two representatives from RUSNANO:
• Anatoly Chubais - RUSNANO, Chief Executive Officer;
• Oleg Kiselev - RUSNANO, Deputy Chief Executive Officer;
Two independent Directors:
• Lord Skidelsky – Member of Parliament; Economist
• Michael Carter – former International Bank for Reconstruction and Development Regional Director for Russia, India and the Baltic states
One representative from RUSNANO Capital LLC:
• Irina Rapoport - RUSNANO Capital LLC, Chief Executive Officer.

“Our intention is to render integral support to our partners as per issues concerning gaining access to investments in Russian research activities and challenging projects,” - Irina Rapoport said. “We are already aware of global players’ interest in different research and development activities, including such areas as: alternative power-engineering, innovative materials, biotechnologies and pharmacology. We trust that we’ll be able to considerably increase the volume of foreign investments in leading Russian research and development activities as well as make our contribution to world innovative technologies transfer to Russia.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.